New AI-Powered Free Company Valuation tool for any company in the world. Upload a PDF financial statement to receive an instant report with customizable forecasts, credit score, default probability and key financial metrics. Try Now for Free →
- Get an AI-powered company valuation or credit risk report in just 2 minutes
- Get reports of any company in the world with a financial statement in any language
- Upload a PDF financial statement to receive an instant report with customizable forecasts, credit score, default probability and key financial metrics
Amplified Medicine ApS — Credit Rating and Financial Key Figures
Credit rating
Company information
About Amplified Medicine ApS
Amplified Medicine ApS (CVR number: 43252674) is a company from KØBENHAVN. The company recorded a gross profit of -17.9 kDKK in 2025. The operating profit was -17.9 kDKK, while net earnings were -9.2 kDKK. The profitability of the company measured by Return on Assets (ROA) was -47.5 %, which can be considered poor and Return on Equity (ROE) was -83.5 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -63.9 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. Amplified Medicine ApS's liquidity measured by quick ratio was 0.6 which is at a low level. Thus, the company may face difficulties in addressing its short-term obligations with its available liquid assets.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Volume | ||||
| Net sales | ||||
| Gross profit | 20.27 | -50.90 | -21.79 | -17.90 |
| EBIT | 4.27 | -50.90 | -21.79 | -17.90 |
| Net earnings | 3.01 | -43.18 | -21.98 | -9.15 |
| Shareholders equity total | 43.01 | -0.17 | -22.15 | -31.30 |
| Balance sheet total (assets) | 86.76 | 30.87 | 4.20 | 17.72 |
| Net debt | -86.76 | -18.83 | -0.04 | 13.71 |
| Profitability | ||||
| EBIT-% | ||||
| ROA | 4.9 % | -86.4 % | -75.9 % | -47.5 % |
| ROE | 7.0 % | -116.9 % | -125.3 % | -83.5 % |
| ROI | 9.9 % | -232.2 % | -5211.2 % | -158.0 % |
| Economic value added (EVA) | 4.27 | -42.58 | -21.83 | -11.60 |
| Solvency | ||||
| Equity ratio | 49.6 % | -0.6 % | -84.0 % | -63.9 % |
| Gearing | -477.7 % | -72.4 % | ||
| Relative net indebtedness % | ||||
| Liquidity | ||||
| Quick ratio | 2.0 | 1.0 | 0.2 | 0.6 |
| Current ratio | 2.0 | 1.0 | 0.2 | 0.6 |
| Cash and cash equivalents | 86.76 | 19.67 | 0.04 | 8.96 |
| Capital use efficiency | ||||
| Trade debtors turnover (days) | ||||
| Net working capital % | ||||
| Credit risk | ||||
| Credit rating | BB | BB | BB | BB |
Variable visualization
Roles
Companies in the same industry
- Company information
- Financial data
- Credit risk data
- All 400,000+ Danish companies
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.